Szela Mary T's Form 4 filing
TriSalus Life Sciences, Inc. (TLSI) · filed Mar 20, 2026
- Accession no.
- 0001628280-26-020186
- Filed
- Mar 20, 2026
- Trade date
- Mar 11-17, 2026
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $79.4K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szela Mary TCIK 0001410289 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Common Stock | SSaleDisposed | −4,358 | $4.13 | −$17,998.54 | 768,931 | Direct | |
| Mar 17, 2026 | Common Stock | SSaleDisposed | −15,944 | $3.85 | −$61,384.4 | 752,987 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.